HSBC has agreed to sell its Singapore life and health insurance business to Germany’s Allianz for about US$2.09 billion (reported as roughly US$2.08–US$2.1 billion). Multiple outlets report the deal is valued at around S$2.7 billion and is expected to complete in the first half of 2027, subject to regulatory approvals and other customary conditions.
HSBC says the disposal is expected to generate a pre-tax gain of about US$1.8 billion and improve its capital position, including a projected boost to its common equity tier 1 ratio by up to 15 basis points. The Financial Times also frames the sale as part of HSBC’s broader “ongoing simplification” efforts.
As part of the agreement, HSBC and Allianz will enter a 15-year exclusive bancassurance and distribution arrangement. Under this partnership, Allianz will provide insurance and other solutions to HSBC customers in Singapore through an exclusive channel for the duration stated in the deal terms. The transaction reflects HSBC’s move to restructure its business mix while continuing to offer insurance products to customers via Allianz.
